Filing Details

Accession Number:
0001209191-10-017629
Form Type:
4
Zero Holdings:
No
Publication Time:
2010-03-17 13:00:00
Reporting Period:
2010-03-15
Filing Date:
2010-03-17
Accepted Time:
2010-03-17 16:45:33
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
824068 Ats Medical Inc ATSI Orthopedic, Prosthetic & Surgical Appliances & Supplies (3842) 411595629
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1441690 A Craig Swandal 3905 Annapolis Lane North
Plymouth MN 55447
Vice President Of Operations No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2010-03-15 13,213 $0.00 30,516 No 4 M Direct
Common Stock Disposition 2010-03-16 5,312 $2.50 25,204 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 M Direct
No 4 S Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Restricted Stock Units Disposition 2010-03-15 13,213 $0.00 66,065 $0.00
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
52,852 2010-03-15 2014-03-15 No 4 M Direct
Reported Derivative Holdings
Sec. Name Sec. Type Price Date Expiration Date Amount Remaning Holdings Nature of Ownership
Common Stock Restricted Stock Units $0.00 2009-08-11 2013-08-11 68,000 68,000 Direct
Common Stock Restricted Stock Units $0.00 2011-03-01 2015-03-01 53,410 53,410 Direct
Common Stock Restricted Stock Units $0.00 2011-03-01 2015-03-01 15,000 15,000 Direct
Expiration Date Amount Remaning Holdings Nature of Ownership
2013-08-11 68,000 68,000 Direct
2015-03-01 53,410 53,410 Direct
2015-03-01 15,000 15,000 Direct
Footnotes
  1. Includes shares held in Employee Stock Purchase Plan as of January 31, 2010.
  2. The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on June 17, 2009.
  3. The price reported is the weighted average sale price for the transactions reported. The prices received ranged from $2.50 to $2.58. The reporting person will provide to the issuer, a security holder of the issuer, or the SEC staff, upon request, full information regarding the number of shares sold at each price within the range.
  4. 1 unit for 1 share of Common Stock
  5. Vests in 20% annual cumulative installments beginning the date shown.
  6. Represents last vesting date.